<DOC>
	<DOCNO>NCT02199756</DOCNO>
	<brief_summary>The purpose study find whether indomethacin encapsulate within nanovector stop contraction pregnant human uterine tissue . Preterm delivery major contributor newborn death . The treatment preterm labor include medication stop contraction within uterus , womb . Indomethacin effective stop uterine contraction , cross placenta unborn baby cause problem baby . Nanovectors use direct delivery medication . If indomethacin deliver directly uterus use nanovector , may ideal medication treat preterm labor . We hypothesize nanovectors load indomethacin reduce uterine contraction .</brief_summary>
	<brief_title>Nanovectors Prevent Placental Passage Tocolytic Agents</brief_title>
	<detailed_description>This prospective observational study . Subjects undergo biopsy middle upper margin uterine incision measure 4 x 2 x 2 cm . This perform manage doctor time cesarean section delivery baby . Once tissue obtain , site close use suture similar usual closure uterus cesarean section . This biopsy take laboratory test whether nanovector increase decrease contraction uterus . Once test finish , tissue frozen test absence presence nanovector within tissue .</detailed_description>
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Tocolytic Agents</mesh_term>
	<criteria>Pregnant woman undergo elective cesarean section great 37 week Known infection</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Uterine contraction</keyword>
	<keyword>Indomethacin</keyword>
	<keyword>Nanovectors</keyword>
</DOC>